Katie reflects on her sweeping first season tackling topics like the spread of online hate and the hype of CBD, not to mention one-on-one interviews with some headline-grabbing names, including Greta Gerwig and Ronan Farrow. But while Next Question takes a brief hiatus to prepare for the next big season, Katie wants to know, what are the issues that keep you up at night? Find out how to connect with Katie, and your next question could be explored in season 2, coming in early 2020.

 Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Katie reflects on her sweeping first season tackling topics like the spread of online hate and the hype of CBD, not to mention one-on-one interviews with some headline-grabbing names, including Greta Gerwig and Ronan Farrow. But while Next Question takes a brief hiatus to prepare for the next big season, Katie wants to know, what are the issues that keep you up at night? Find out how to connect with Katie, and your next question could be explored in season 2, coming in early 2020. Learn more about your ad-choices at <a href="https://www.iheartpodcastnetwork.com">https://www.iheartpodcastnetwork.com</a>

Tired of political headlines that feel like déjà vu? Wondering if you actually need to care about every controversy? This season, Katie’s asking those same questions—and talking to the people who have real answers. From political insiders to sharp-eyed journalists, she’s breaking down what’s worth your attention (and what’s not), with smarts, sanity, and even a little humor. Because none of us can be tuned in 24/7—but we can stay informed without losing our minds. 

Tune in every Thursday and join Katie Couric and her guests for a conversation on NEXT QUESTION.

Tired of political headlines that feel like d&eacute;j&agrave; vu? Wondering if you actually need to care about every controversy? This season, Katie&rsquo;s asking those same questions&mdash;and talking to the people who have real answers. From political insiders to sharp-eyed journalists, she&rsquo;s breaking down what&rsquo;s worth your attention (and what&rsquo;s not), with smarts, sanity, and even a little humor. Because none of us can be tuned in 24/7&mdash;but we can stay informed without losing our minds.&nbsp;
Tune in every Thursday and join Katie Couric and her guests for a conversation on NEXT QUESTION.

Next Question with Katie Couric

Hey, listeners: What are your next questions?

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/e0713fd4-0ca9-4724-b1a0-ae2800615ce6/transcript

Katie turns to veteran New York Times correspondent David Sanger to help make sense of a whirlwind few weeks in national security. Sanger explains why President Trump is using the U.S. military in ways he’s never seen in the five presidencies he’s covered—from sinking more than 20 boats in the Caribbean to deploying the National Guard in cities without clear emergencies. Katie presses him on the unanswered questions around those strikes, including a reported second hit on a burning boat and why the administration won’t release basic information.They also dig into the leaked Russia-Ukraine peace plan and the questions raised about how closely it aligns with Kremlin preferences. And as they discuss the tragic killing of the National Guard member in D.C., Sanger makes the case for why America still owes its Afghan allies protection—now more than ever.

Katie turns to veteran New York Times correspondent David Sanger to help make sense of a whirlwind few weeks in national security. Sanger explains why President Trump is using the U.S. military in ways he&rsquo;s never seen in the five presidencies he&rsquo;s covered&mdash;from sinking more than 20 boats in the Caribbean to deploying the National Guard in cities without clear emergencies. Katie presses him on the unanswered questions around those strikes, including a reported second hit on a burning boat and why the administration won&rsquo;t release basic information.They also dig into the leaked Russia-Ukraine peace plan and the questions raised about how closely it aligns with Kremlin preferences. And as they discuss the tragic killing of the National Guard member in D.C., Sanger makes the case for why America still owes its Afghan allies protection&mdash;now more than ever.

David Sanger

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/6739090f-6cd5-402f-90b3-b3a90027a32e/transcript

In this special live episode of Next Question with Katie Couric, recorded at the 92nd Street Y, New York, Katie sits down with beauty icon Bobbi Brown to talk about her new memoir Still Bobbi: A Masterclass in Leading an Authentic Life. The two longtime friends share stories from Bobbi’s trailblazing career — from Bobbi’s guest appearances as a regular contributor on the Today Show to the creation of Bobbi Brown Cosmetics and her new beauty venture, Jones Road. With humor and heart, they dig into what it means to stay true to yourself, build resilience, and reinvent at any age.

In this special live episode of Next Question with Katie Couric, recorded at the 92nd Street Y, New York, Katie sits down with beauty icon Bobbi Brown to talk about her new memoir Still Bobbi: A Masterclass in Leading an Authentic Life. The two longtime friends share stories from Bobbi&rsquo;s trailblazing career &mdash; from Bobbi&rsquo;s guest appearances as a regular contributor on the Today Show to the creation of Bobbi Brown Cosmetics and her new beauty venture, Jones Road. With humor and heart, they dig into what it means to stay true to yourself, build resilience, and reinvent at any age.

Bobbi Brown

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/3eb94f33-1998-4c64-9ad1-b3a0016663e4/transcript

CAR T therapy has delivered remarkable results for people with certain blood cancers—sometimes sending aggressive disease into deep remission after a single infusion. But today, only about 20% of eligible patients can actually get it. In this episode, sponsored by our partners at Allogene Therapeutics, Katie sits down with Dr. Zachary Roberts to unpack why access remains so limited and how new allogeneic (or “off-the-shelf”) CAR T therapies could be a turning point. They discuss how using healthy donor T-cells, rather than a patient’s own, may help bypass manufacturing hurdles and bring advanced treatment to more oncologists, more hospitals, and more communities. To learn more, visit Alpha3trial.com. #AllogenePartner

CAR T therapy has delivered remarkable results for people with certain blood cancers&mdash;sometimes sending aggressive disease into deep remission after a single infusion. But today, only about 20% of eligible patients can actually get it. In this episode, sponsored by our partners at Allogene Therapeutics, Katie sits down with Dr. Zachary Roberts to unpack why access remains so limited and how new allogeneic (or &ldquo;off-the-shelf&rdquo;) CAR T therapies could be a turning point. They discuss how using healthy donor T-cells, rather than a patient&rsquo;s own, may help bypass manufacturing hurdles and bring advanced treatment to more oncologists, more hospitals, and more communities. To learn more, visit&nbsp;<a href="https://alpha3trial.com/?utm_source=podcast&amp;utm_medium=banner&amp;utm_campaign=KCM_podcast&amp;utm_id=alpha3">Alpha3trial.com</a>. #AllogenePartner

A CAR T Revolution: Allogene is Bringing Lifesaving Cancer Treatment to More Patients

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/ff7fcf87-9947-425a-ba37-b39c0039bda3/transcript

Hey, listeners: What are your next questions?

In 1 playlist(s)

Next Question with Katie Couric

Social links

Follow podcast

Recent clips